Simple-Virilizing Congenital adrenal hyperplasia sustained by five mutations on the CYP21A2 gene

被引:0
|
作者
Agrimonti, Gloria [1 ]
Spaggiari, Giorgia [2 ,3 ]
Menabo, Soara [4 ]
Vezzani, Silvia [5 ]
Magnani, Elisa [5 ]
Frasoldati, Andrea [5 ]
Granata, Antonio R. M. [2 ,3 ]
Santi, Daniele [1 ,2 ,3 ]
机构
[1] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy
[2] Azienda Osped Univ Modena, Dept Med Specialties, Unit Endocrinol, Modena, Italy
[3] Azienda Osped Univ Modena, Dept Med Specialties, Unit Androl & Sexual Med, Unit Endocrinol, Modena, Italy
[4] IRCCS Azienda Osped Univ Bologna, Med Genet Unit, Bologna, Italy
[5] Azienda USL IRCCS Reggio Emilia, Endocrinol Unit, Reggio Emilia, Italy
来源
BIOMEDICAL RESEARCH AND THERAPY | 2024年 / 11卷 / 07期
关键词
Congenital adrenal hyperplasia; Testosterone; 21-hydroxylase gene; STEROID 21-HYDROXYLASE DEFICIENCY; GENOTYPE-PHENOTYPE CORRELATION; VARIANTS;
D O I
10.15419/bmrat.v11i7.905
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Classical congenital adrenal hyperplasia is a genetic disorder characterized by defects in the steroidogenesis cascade, mainly due to 21-hydroxylase enzyme deficiency. The phenotype can vary from the most severe salt-wasting syndrome to the less severe simple-virilizing form. The genotype-phenotype correlation is complex, and it is expected that the higher the number of mutations detected, the worse the phenotype would be. Moreover, when more than one mutation occurs in the same patient, the phenotype should be the result of the most severe mutation detected. Case Presentation: This is the case of a 49-year-old Caucasian man with simple virilizing congenital adrenal hyperplasia, diagnosed at two years of age due to neonatal presentation of ambiguous genitalia. The karyotype was 46, XX, the phenotype was male, and hormonal evaluations highlighted cortisol deficiency, which required cortisone acetate replacement therapy. Gonads were removed during infancy, surgical interventions were performed to align physical attributes with his male gender identity, and the patient underwent testosterone replacement therapy. During adulthood, while compensation for cortisone acetate was reached, managing testosterone therapy proved to be challenging, achieved after the introduction of a low dose of dexamethasone (0.125 mg daily) and testosterone gel 2% 30 mg daily. Genetic analysis unraveled five different heterozygous pathogenic variants on the CYP21A2 gene. One mutation was detected on the maternal allele, while the remaining four were found on the second allele. Three of these mutations were proven to be pathognomonic for the salt-wasting form. Conclusion:This case underscored the intricate and heterogeneous correlation between genotype and phenotype in simple-virilizing congenital adrenal hyperplasia, illustrated by a patient with a rare occurrence of five distinct pathogenic mutations on the CYP21A2 gene. Although three of the five mutations detected are related to the salt-wasting congenital adrenal hyperplasia, only a simple-virilizing form was detected here. Moreover, although it is supposed that the higher the number of mutations detected, the worse the phenotype should be, here we described a simple-virilizing form in a patient with five mutations on the CYP21A2 gene.
引用
收藏
页码:6583 / 6591
页数:9
相关论文
共 50 条
  • [41] Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
    Dung V Chi
    Thinh H Tran
    Duc H Nguyen
    Long H Luong
    Phuong T Le
    Minh H Ta
    Huong T T Ngo
    Mai P Nguyen
    Tuan P Le-Anh
    Dat P Nguyen
    The-Hung Bin
    Van T Ta
    Van K Tran
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (05):
  • [42] Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia
    Prado, Mayara Jorgens
    de Castro, Simone Martins
    Kopacek, Cristiane
    de Mello, Maricilda Palandi
    Rispoli, Thaiane
    Grandi, Tarciana
    Dornelles da Silva, Claudia Maria
    Rosa Rossetti, Maria Lucia
    MOLECULAR DIAGNOSIS & THERAPY, 2017, 21 (06) : 663 - 675
  • [43] MLPA based identification of compound heterozygous CYP21A2 mutations in Polish patient with congenital adrenal hyperplasia
    Tomaszewska, A.
    Straburzynski, M.
    Piechota, M.
    Lacna, K.
    Materna-Kiryluk, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 901 - 901
  • [44] Dual Heterozygous Mutations in CYP21A2 and CYP11B1 in a Case of Nonclassic Congenital Adrenal Hyperplasia
    Frontera, Eric D.
    Brown, Joshua J.
    Ghareebian, Hagop
    Mariash, Cary
    AACE CLINICAL CASE REPORTS, 2022, 8 (06): : 271 - 274
  • [45] CYP21 mutations and congenital adrenal hyperplasia
    Lee, HH
    CLINICAL GENETICS, 2001, 59 (05) : 293 - 301
  • [46] High carrier frequency of CYP21A2 gene mutations in Southern India - underscoring the need for genetic testing in Congenital Adrenal Hyperplasia
    Ravichandran, Lavanya
    Paul, Shriti
    Rekha, A.
    Asha, H. S.
    Mathai, Sarah
    Simon, Anna
    Danda, Sumita
    Thomas, Nihal
    Chapla, Aaron
    ENDOCRINE, 2024, 85 (01) : 363 - 369
  • [47] The chimeric CYP21A1P/CYP21A2 and TNXA/TNXB gene deficiencies in patients with Congenital Adrenal Hyperplasia
    Fanis, Pavlos
    Toumba, Meropi
    Chrysostomou, Anna Katerina
    Mousikou, Maria
    Nicolaou, Stella
    Kyriakou, Andreas
    Neocleous, Vassos
    Phylactou, Leonidas A.
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 78 - 78
  • [48] Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia
    Torres, N
    Mello, MP
    Germano, CMR
    Elis, LLK
    Moreira, AC
    Castro, M
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2003, 36 (10) : 1311 - 1318
  • [49] The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene
    Livadas, S.
    Dracopoulou, M.
    Dastamani, A.
    Sertedaki, A.
    Maniati-Christidi, M.
    Magiakou, A. -M.
    Kanaka-Gantenbein, C.
    Chrousos, G. P.
    Dacou-Voutetakis, C.
    CLINICAL ENDOCRINOLOGY, 2015, 82 (04) : 543 - 549
  • [50] Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: An Update on Genetic Analysis of CYP21A2 Gene
    Carvalho, Berta
    Marques, C. Joana
    Santos-Silva, Rita
    Fontoura, Manuel
    Carvalho, Davide
    Carvalho, Filipa
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2021, 129 (07) : 477 - 481